ZOFIN Trademark

Trademark Overview

On Monday, July 13, 2020, a trademark application was filed for ZOFIN with the United States Patent and Trademark Office. The USPTO has given the ZOFIN trademark a serial number of 90050511. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, February 27, 2024. This trademark is owned by Organicell Regenerative Medicine, Inc.. The ZOFIN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biologically derived products developed from perinatal tissue material for medical and medical regenerative purposes, namely, biological tissue grafts, implants comprising living tissue, surgical implants comprising living tissue, and biological implants for cushioning tissues and supporting tissue repair and homeostasis

Biologically derived products developed from perinatal tissue material in the nature of cultured biological tissue and non-cultured biological tissue, for aesthetic purposes, other than for medical or veterinary purposes
zofin

General Information

Serial Number90050511
Word MarkZOFIN
Filing DateMonday, July 13, 2020
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements

Goods and ServicesBiologically derived products developed from perinatal tissue material for medical and medical regenerative purposes, namely, biological tissue grafts, implants comprising living tissue, surgical implants comprising living tissue, and biological implants for cushioning tissues and supporting tissue repair and homeostasis
Goods and ServicesBiologically derived products developed from perinatal tissue material in the nature of cultured biological tissue and non-cultured biological tissue, for aesthetic purposes, other than for medical or veterinary purposes

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code001
First Use Anywhere DateTuesday, November 10, 2020
First Use In Commerce DateTuesday, November 10, 2020
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 10, 2020
Primary Code005
First Use Anywhere DateTuesday, November 10, 2020
First Use In Commerce DateTuesday, November 10, 2020

Trademark Owner History

Party NameOrganicell Regenerative Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFt. Lauderdale, FL 33328
Party NameOrganicell Regenerative Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33136

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 27, 2024ASSIGNED TO LIE
Thursday, October 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 5, 2023NON-FINAL ACTION E-MAILED
Wednesday, July 5, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, June 10, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 18, 2023USE AMENDMENT FILED
Friday, June 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 18, 2022SOU EXTENSION 3 GRANTED
Friday, November 18, 2022SOU EXTENSION 3 FILED
Friday, November 18, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 2 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 2 FILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 16, 2021SOU EXTENSION 1 GRANTED
Tuesday, November 16, 2021SOU EXTENSION 1 FILED
Tuesday, November 16, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 4, 2021ASSIGNED TO LIE
Thursday, October 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 27, 2020NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, October 27, 2020EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, October 27, 2020COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, October 27, 2020EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, October 22, 2020ASSIGNED TO EXAMINER
Monday, August 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 16, 2020NEW APPLICATION ENTERED

Related Keywords

zofin tissue biological medical purposes implants biologically comprising perinatal cultured derived